TJ191

TJ191 is a selective anti-cancer agent, targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells.

1522415-97-9

≥ 2 years

>98% (HPLC)

255.38

C13H21NO2S

Research use only, not for human use.

Apoptosis

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

DF3128-BP 1 mg

Ask

E-EL-RB2288-01 24 Tests

Ask

E-EL-RB2288-02 48 Tests

Ask

E-EL-RB2288-03 96 Tests

Ask

CABT-L2961-01 100 µl, 500 µl

Ask

CABT-L2961-02 100 uL, 500 uL

Ask